Transcatheter Aortic Valve Replacement With Early- and New-Generation Devices in Bicuspid Aortic Valve Stenosis.

Yoon, Sung-Han; Lefevre, Thierry; Ahn, Jung-Ming; Perlman, Gidon Y; Dvir, Danny; Latib, Azeem; Barbanti, Marco; Deuschl, Florian; De Backer, Ole; Blanke, Philipp; Modine, Thomas; Pache, Gregor; Neumann, Franz-Josef; Ruile, Philipp; Arai, Takahide; Ohno, Yohei; Kaneko, Hidehiro; Tay, Edgar; Schofer, Niklas; Holy, Erik W; Luk, Ngai H V; Yong, Gerald; Lu, Qingsheng; Kong, William K F; Hon, Jimmy; Kao, Hsien-Li; Lee, Michael; Yin, Wei-Hsian; Park, Duk-Woo; Kang, Soo-Jin; Lee, Seung-Whan; Kim, Young-Hak; Lee, Cheol Whan; Park, Seong-Wook; Kim, Hyo-Soo; Butter, Christian; Khalique, Omar K; Schaefer, Ulrich; Nietlispach, Fabian; Kodali, Susheel K; Leon, Martin B; Ye, Jian; Chevalier, Bernard; Leipsic, Jonathon; Delgado, Victoria; Bax, Jeroen J; Tamburino, Corrado; Colombo, Antonio; Sondergaard, Lars; Webb, John G; Park, Seung-Jung
Journal of the American College of Cardiology
2016Sep ; 68 ( 11 ) :1195-1205.
저자 상세정보
Yoon, Sung-Han -
Lefevre, Thierry -
Ahn, Jung-Ming -
Perlman, Gidon Y -
Dvir, Danny -
Latib, Azeem -
Barbanti, Marco -
Deuschl, Florian -
De Backer, Ole -
Blanke, Philipp -
Modine, Thomas -
Pache, Gregor -
Neumann, Franz-Josef -
Ruile, Philipp -
Arai, Takahide -
Ohno, Yohei -
Kaneko, Hidehiro -
Tay, Edgar -
Schofer, Niklas -
Holy, Erik W -
Luk, Ngai H V -
Yong, Gerald -
Lu, Qingsheng -
Kong, William K F -
Hon, Jimmy -
Kao, Hsien-Li -
Lee, Michael -
Yin, Wei-Hsian -
Park, Duk-Woo -
Kang, Soo-Jin -
Lee, Seung-Whan -
Kim, Young-Hak -
Lee, Cheol Whan -
Park, Seong-Wook -
Kim, Hyo-Soo -
Butter, Christian -
Khalique, Omar K -
Schaefer, Ulrich -
Nietlispach, Fabian -
Kodali, Susheel K -
Leon, Martin B -
Ye, Jian -
Chevalier, Bernard -
Leipsic, Jonathon -
Delgado, Victoria -
Bax, Jeroen J -
Tamburino, Corrado -
Colombo, Antonio -
Sondergaard, Lars -
Webb, John G -
Park, Seung-Jung -
ABSTRACT
BACKGROUND: Few studies have evaluated the clinical outcomes of transcatheter aortic valve replacement (TAVR) in?patients with bicuspid aortic valve stenosis (AS). Particularly, limited data exist comparing the results of TAVR with new-generation devices versus early-generation devices. OBJECTIVES: This study sought to evaluate the clinical outcomes of TAVR for bicuspid AS with early- and new-generation devices.

METHODS: The Bicuspid TAVR Registry is an international multicenter study enrolling consecutive patients with bicuspid AS undergoing TAVR between April 2005 and May?2015.

RESULTS: Of 301 patients, 199 patients (71.1%) were treated with early-generation devices (Sapien XT [Edwards Lifesciences Corporation, Irvine, California]: n?= 87; CoreValve [Medtronic, Minneapolis, Minnesota]: n?= 112) and 102?with new-generation devices (Sapien 3 [Edwards Lifesciences Corporation]: n?= 91; Lotus [Boston Scientific Corporation, Marlborough, Massachusetts]: n?= 11). The mean Society of Thoracic Surgeons score was 4.7 짹 5.2 without significant differences between groups (4.6 짹 5.1 vs. 4.9 짹 5.4; p?= 0.57). Overall, all-cause mortality rates were 4.3% at?30 days and 14.4% at 1 year. Moderate or severe paravalvular leak was absent and significantly less frequent with new-generation compared to early-generation devices (0.0% vs. 8.5%; p?= 0.002), which resulted in a higher device success rate (92.2% vs. 80.9%; p?= 0.01). There were no differences between early- and new-generation devices in stroke (2.5% vs. 2.0%; p?> 0.99), life-threatening bleeding (3.5% vs. 2.9%; p > 0.99), major vascular complication (4.5% vs. 2.9%; p?= 0.76), stage 2 to 3 acute kidney injury (2.5% vs. 2.9%; p > 0.99), early safety endpoints (15.1% vs. 10.8%; p?= 0.30), and 30-day all-cause mortality (4.5% vs. 3.9%; p > 0.99).

CONCLUSIONS: The clinical outcomes of TAVR in patients with bicuspid AS were favorable. New-generation devices were associated with less paravalvular leak and, hence, a higher device success rate than early-generation devices. (The?Bicuspid Aortic Stenosis Following Transcatheter Aortic Valve Replacement Registry [Bicuspid TAVR]; NCT02394184). CI - Copyright ??2016 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.
mortality; new device; paravalvular leak.
MESH
Aged, Aortic Valve/*abnormalities/surgery, Aortic Valve Stenosis/etiology/*surgery, Equipment Design, Female, Heart Valve Diseases/complications/*surgery, Humans, Male, Transcatheter Aortic Valve Replacement/*instrumentation
링크

주제코드
주제명(Target field)
연구대상(Population)
연구참여(Sample size)
대상성별(Gender)
질병특성(Condition Category)
연구환경(Setting)
연구설계(Study Design)
연구기간(Period)
중재방법(Intervention Type)
중재명칭(Intervention Name)
키워드(Keyword)
유효성결과(Recomendation)
New-generation devices were associated with less paravalvular leak and, hence, a higher device success rate than early-generation devices. (The Bicuspid Aortic Stenosis Following Transcatheter Aortic Valve Replacement Registry [Bicuspid TAVR]
연구비지원(Fund Source)
근거수준평가(Evidence Hierarchy)
출판년도(Year)
참여저자수(Authors)
대표저자
DOI
10.1016/j.jacc.2016.06.041.
KCD코드
ICD 03
건강보험코드